Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancer

Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancer

US Patent 8247408 · Granted Aug 21, 2012

Estimated economic value: $12,923,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic adenosine receptor antagonists2025
Anti-cancer/anti-fibrosis compounds2024
Heterocyclic adenosine receptor antagonists2023
Pharmaceutical composition comprising dutasteride and propylene glycol monolaura2020
RORγ modulators2018
Inhibitors of Bruton's tyrosine kinase2018
Protein kinase inhibitor containing pyrrolopyridazine derivative2017
Inhibitors of bruton's tyrosine kinase2017
Inhibitors of Bruton's tyrosine kinase2017
Inhibitors of Bruton's tyrosine kinase2017
Pyrrolopyrimidine compounds as kinase inhibitors2017
Inhibitors of Bruton's tyrosine kinase2017